Taiwan
· Delayed Price · Currency is TWD Concord Medical Statistics
Total Valuation
Concord Medical has a market cap or net worth of TWD 828.33 million. The enterprise value is 708.96 million.
| Market Cap | 828.33M |
| Enterprise Value | 708.96M |
Important Dates
The next estimated earnings date is Monday, August 4, 2025.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | Apr 10, 2025 |
Share Statistics
Concord Medical has 33.33 million shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 33.33M |
| Shares Outstanding | 33.33M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 11.33M |
Valuation Ratios
The trailing PE ratio is 16.79.
| PE Ratio | 16.79 |
| Forward PE | n/a |
| PS Ratio | 0.93 |
| PB Ratio | 1.19 |
| P/TBV Ratio | 1.19 |
| P/FCF Ratio | 11.18 |
| P/OCF Ratio | 5.57 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.82, with an EV/FCF ratio of 9.57.
| EV / Earnings | 14.30 |
| EV / Sales | 0.80 |
| EV / EBITDA | 4.82 |
| EV / EBIT | 11.66 |
| EV / FCF | 9.57 |
Financial Position
The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.29.
| Current Ratio | 2.21 |
| Quick Ratio | 2.18 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.37 |
| Debt / FCF | 2.72 |
| Interest Coverage | 17.11 |
Financial Efficiency
Return on equity (ROE) is 7.19% and return on invested capital (ROIC) is 4.25%.
| Return on Equity (ROE) | 7.19% |
| Return on Assets (ROA) | 3.28% |
| Return on Invested Capital (ROIC) | 4.25% |
| Return on Capital Employed (ROCE) | 6.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.77 |
| Inventory Turnover | 238.64 |
Taxes
In the past 12 months, Concord Medical has paid 12.88 million in taxes.
| Income Tax | 12.88M |
| Effective Tax Rate | 20.62% |
Stock Price Statistics
The stock price has decreased by -3.14% in the last 52 weeks. The beta is 0.32, so Concord Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -3.14% |
| 50-Day Moving Average | 26.22 |
| 200-Day Moving Average | 26.05 |
| Relative Strength Index (RSI) | 32.15 |
| Average Volume (20 Days) | 3,072 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Concord Medical had revenue of TWD 889.85 million and earned 49.57 million in profits. Earnings per share was 1.48.
| Revenue | 889.85M |
| Gross Profit | 109.62M |
| Operating Income | 60.81M |
| Pretax Income | 62.45M |
| Net Income | 49.57M |
| EBITDA | 145.00M |
| EBIT | 60.81M |
| Earnings Per Share (EPS) | 1.48 |
Balance Sheet
The company has 321.25 million in cash and 201.87 million in debt, giving a net cash position of 119.37 million or 3.58 per share.
| Cash & Cash Equivalents | 321.25M |
| Total Debt | 201.87M |
| Net Cash | 119.37M |
| Net Cash Per Share | 3.58 |
| Equity (Book Value) | 697.26M |
| Book Value Per Share | 20.92 |
| Working Capital | 345.47M |
Cash Flow
In the last 12 months, operating cash flow was 148.83 million and capital expenditures -74.72 million, giving a free cash flow of 74.12 million.
| Operating Cash Flow | 148.83M |
| Capital Expenditures | -74.72M |
| Free Cash Flow | 74.12M |
| FCF Per Share | 2.22 |
Margins
Gross margin is 12.32%, with operating and profit margins of 6.83% and 5.57%.
| Gross Margin | 12.32% |
| Operating Margin | 6.83% |
| Pretax Margin | 7.02% |
| Profit Margin | 5.57% |
| EBITDA Margin | 16.29% |
| EBIT Margin | 6.83% |
| FCF Margin | 8.33% |
Dividends & Yields
This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 4.35%.
| Dividend Per Share | 1.10 |
| Dividend Yield | 4.35% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 67.24% |
| Buyback Yield | -0.08% |
| Shareholder Yield | 4.27% |
| Earnings Yield | 5.98% |
| FCF Yield | 8.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Concord Medical has an Altman Z-Score of 2.62 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.62 |
| Piotroski F-Score | 6 |